«

»

Nov 28

Nallathamby Laboratory in the Press for Novel Approach to CAR-T Therapy

Categories:

Berthiaume Institute for Precision Health, Harper Cancer Research Institute, Hybrid nanoparticles, Immunotherapy

by Prakash

Glad to see that our work on using nanoparticle-based ON-OFF switches for CAR-T cells therapy against solid tumors is getting positive traction in the local media. Here is my interview with Kylie Veleta of Inside Indiana business on what motivates us to keep pushing forward. The website is Indiana business focused. The interview was part of the breast cancer awareness month. The full interview can be read at http://www.insideindianabusiness.com/story/39391168/researcher-tweaks-t-cells-for-tumors

Nallathamby and his team are developing a double-sided nanoparticle.

Janus nanoparticles that are being developed as ON-OFF switches for CAR-T cells in anti-caner therapy

This post has no tag